Heska to Present at Three Upcoming Institutional Investor Conferences
Heska Corporation (NASDAQ: HSKA), a leader in advanced veterinary diagnostics, announced its participation in three institutional investor conferences in March 2023. Key events include the Bank of America Securities Animal Health Summit on March 2, where CEO Kevin Wilson will engage in a virtual fireside chat. The Raymond James Annual Institutional Investors Conference on March 7 will feature Mr. Wilson presenting followed by a Q&A session. Lastly, CFO Catherine Grassman will participate in the Barclays Global Healthcare Conference on March 14. All sessions will have access to webcasts via Heska's Investor Relations website.
- None.
- None.
LOVELAND, Colo., Feb. 23, 2023 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, announced that members of Heska's management team will present at three institutional investor conferences in March 2023.
- Bank of America Securities 2023 Animal Health Summit, March 2. Kevin Wilson, Chief Executive Officer and President, will participate in a virtual fireside discussion at 1:20 p.m. ET.
- Raymond James Virtual 44th Annual Institutional Investors Conference, March 7. Mr. Wilson will present at 2:15 p.m. ET and the presentation will be immediately followed by a question and answer session.
- Barclays Global Healthcare Conference, March 14. Catherine Grassman, Executive Vice President, Chief Financial Officer, will participate in a fireside discussion at 3:05 p.m. ET.
Company management will also participate in one-on-one meetings at each event. Event webcasts and presentations can be accessed through the links provided on the Heska Investor Relations website, https://ir.heska.com/events/. For additional information, please contact Heska Investor Relations at investorrelations@heska.com.
About Heska
Heska Corporation (NASDAQ: HSKA) sells, manufactures, markets, and supports diagnostic and specialty products and solutions for veterinary practitioners. Heska's portfolio includes point-of-care diagnostic laboratory instruments and consumables including rapid assay diagnostic products and digital cytology services; point-of-care digital imaging diagnostic products; local and cloud-based data services; practice information management software ("PIMS") and related software and support; reference laboratory testing; allergy testing and immunotherapy; heartworm preventive products; and vaccines. Heska's primary focus is supporting companion animal veterinarians in providing care to their patients. Heska's business is composed of two operating and reportable segments: North America and International. North America consists of the United States, Canada and Mexico. International consists of geographies outside of North America, primarily in Germany, Italy, Spain, France, Switzerland, Australia and Malaysia. The Company's strategic focus on point-of-care diagnostic laboratory and imaging products is included in both segments. The North America segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory, and the International segment includes PIMS business and veterinary laboratories. For more information, please visit www.heska.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/heska-to-present-at-three-upcoming-institutional-investor-conferences-301754105.html
SOURCE Heska Corporation
FAQ
What conferences will Heska Corporation (HSKA) present at in March 2023?
Who will represent Heska Corporation at the Bank of America Securities conference?
When is the Raymond James Annual Institutional Investors Conference for Heska Corporation?
What is the schedule for Heska Corporation at the Barclays Global Healthcare Conference?
How can I access webcasts of Heska Corporation's presentations?
